Stereotactic Single-Dose Radiotherapy An Option For Early Lung Cancer
August 28th, 2007
Clinicians from Germany have found stereotactic single-dose radiotherapy to be a safe and effective treatment option for patients with stage I and II non-small cell lung cancer (NSCLC) not amenable to surgery.

